Coco-Scalp®

Coco-Scalp® is a specially formulated ointment treatment for dry scaly scalp conditions such as dandruff, seborrhoeic dermatitis, eczema and psoriasis.

Coco-Scalp® breaks down the itchy scale that builds up on the scalp, allowing the active ingredients to treat the condition, while coconut oil moisturises the skin.


Coco-Scalp® is not a shampoo or a steroid treatment; it is a specially formulated coconut oil compound ointment developed by dermatologists for irritating, itchy scalp conditions such as psoriasis, eczema, seborrhoeic dermatitis and stubborn dandruff.

Active ingredients

Coal tar solution 12% w/w, salicylic acid 2% w/w, sulfur-precipitated 4% w/w.

Dosage

Adults and children over 12 years: Apply to the affected areas of the scalp and remove after one hour using warm water and shampoo.Not suitable for use by children 12 years or less.

Warnings

For external use only.

Avoid contact with eyes.

Replace cap and wash hands immediately after use.

If skin irritation occurs, discontinue use.

Do not use for prolonged periods except on the advice of a doctor or pharmacist.

Do not refrigerate and discard the tube no later than four weeks after opening.

Available pack sizes

40 g

Dose form

Ointment

Can I buy products directly off your website?
Explore our online shop to purchase products directly, or visit our individual brand websites to find stockists for in-store and online purchases.
Where can I report adverse drug reactions?
Please get in touch with us at customer.service@aftpharm.com or go to our Contact Us page.
Where can I find out more about your product range?
You can find further information about our products on the Product page.
I am interested in partnering with you as a licensee/licensor, how do I get in touch?
Please use the enquiry form on the Contact Us page and someone will be in touch.
How can I work at AFT?
If we have any current vacancies, you can find them on the Careers page.
How do I invest in AFT?
Head to our Investors website to find out more about how you can invest with AFT Pharmaceuticals.